Fig. 2: Patient disposition in the non-intensive study.
aWith glasdegib or placebo; bWithout an associated adverse event. N/A not applicable, PK pharmacokinetic.
Fig. 2: Patient disposition in the non-intensive study. | Leukemia
aWith glasdegib or placebo; bWithout an associated adverse event. N/A not applicable, PK pharmacokinetic.
